Association of clostridium difficile infections with acid suppression medications in children

Journal of Pediatrics

Volumn 165, Issue 5, 2014, Pages 979-984.e1

  Nylund, Cade M ^a   Eide, Matilda ^a   Gorman, Gregory H ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PRESCRIPTION DRUG; PROTON PUMP INHIBITOR; ANTACID AGENT;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PRESCRIPTION; RECURRENCE RISK; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; CHEMICALLY INDUCED; CLOSTRIDIUM INFECTIONS; GASTROINTESTINAL DISEASES; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ANTACIDS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; GASTROINTESTINAL DISEASES; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; MALE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84908323839     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.06.062     Document Type: Article

References (39)

1. C.M. Nylund, A. Goudie, J.M. Garza, G. Fairbrother, and M.B. Cohen Clostridium difficile infection in hospitalized children in the United States Arch Pediatr Adolesc Med 165 2011 451 457
2. J. Kim, S.A. Smathers, P. Prasad, K.H. Leckerman, S. Coffin, and T. Zaoutis Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006 Pediatrics 122 2008 1266 1270
3. S. Khanna, L.M. Baddour, W.C. Huskins, P.P. Kammer, W.A. Faubion, and A.R. Zinsmeister The epidemiology of Clostridium difficile infection in children: a population-based study Clin Infect Dis 56 2013 1401 1406
4. J.S. Sammons, P. Toltzis, and T.E. Zaoutis Clostridium difficile Infection in children JAMA 167 2013 567 573
5. J.S. Sammons, and P. Toltzis Recent trends in the epidemiology and treatment of C difficile infection in children Curr Opin Pediatr 25 2013 116 121
6. Y. Vandenplas, C.D. Rudolph, C. Di Lorenzo, E. Hassall, G. Liptak, and L. Mazur Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) J Pediatr Gastroenterol Nutr 49 2009 498 547
7. S. Koletzko, N.L. Jones, K.J. Goodman, B. Gold, M. Rowland, and S. Cadranel Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children J Pediatr Gastroenterol Nutr 53 2011 230 243
8. E.S. Dellon, N. Gonsalves, I. Hirano, G.T. Furuta, C.A. Liacouras, and D.A. Katzka ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE) Am J Gastroenterol 108 2013 679 692 quiz 93
9. J.E. Dominguez-Munoz, J. Iglesias-Garcia, M. Iglesias-Rey, and M. Vilarino-Insua Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts Gut 55 2006 1056 1057
10. P.J. Kahrilas, C.W. Howden, N. Hughes, and M. Molloy-Bland Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease Chest 143 2013 605 612
11. D. Ummarino, E. Miele, P. Masi, A. Tramontano, A. Staiano, and Y. Vandenplas Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children Dis Esophagus 25 2012 671 677
12. J. Wasilewska, J. Semeniuk, B. Cudowska, M. Klukowski, K. Debkowska, and M. Kaczmarski Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease Sleep Med 13 2012 824 830
13. E. Hassall Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it J Pediatr 160 2012 193 198
14. Children's aching stomachs: New research finds young children are increasingly using medications to treat gastrointestinal ailments. Franklin Lakes, NJ: Medco Health Solutions, Inc. http://phx.corporate-ir.net/phoenix.zhtml?c=69641&p=irol-MedcoPressArticle&ID=1058989&highlight=. Accessed July 30, 2014.
15. P. Greene, and D. Moeny Proton pump inhbitors BPCA drug use review and duration of use analysis 2010 Center for Drug Evaluation and Research http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/pediatricadvisorycommittee/ucm214657.pdf Accessed July 30, 2014
16. J.A. Tjon, M. Pe, J. Soscia, and S. Mahant Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease Pharmacotherapy 33 2013 956 971
17. S. Janarthanan, I. Ditah, D.G. Adler, and M.N. Ehrinpreis Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis Am J Gastroenterol 107 2012 1001 1010
18. A. Deshpande, C. Pant, V. Pasupuleti, D.D. Rolston, A. Jain, and N. Deshpande Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis Clin Gastroenterol Hepatol 10 2012 225 233
19. I.M. Tleyjeh, A.B. Abdulhak, M. Riaz, M.A. Garbati, M. Al-Tannir, and F.A. Alasmari The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis PLoS One 8 2013 e56498
20. FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). Rockville, MD; 2012. http://www.fda.gov/drugs/drugsafety/ucm290510.htm. Accessed July 30, 2014.
21. E.A. Mezoff, and M.B. Cohen Acid suppression and the risk of Clostridium difficile infection J Pediatr 163 2013 627 630
22. H.J. Whitaker, M.N. Hocine, and C.P. Farrington The methodology of self-controlled case series studies Stat Methods Med Res 18 2009 7 26
23. C. Rousseau, L. Lemee, A. Le Monnier, I. Poilane, J.L. Pons, and A. Collignon Prevalence and diversity of Clostridium difficile strains in infants J Med Microbiol 60 2011 1112 1118
24. G.E. Schutze, R.E. Willoughby, Committee on Infectious Diseases, and American Academy of Pediatrics Clostridium difficile infection in infants and children Pediatrics 131 2013 196 200
25. Miltiary OneSource demographic reports. Office of the Deputy Assistant Secretary of Defense. http://www.militaryonesource.mil/search?content-id=268828. Accessed July 30, 2014.
26. R. Turco, M. Martinelli, E. Miele, E. Roscetto, M. Del Pezzo, and L. Greco Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection Aliment Pharmacol Ther 31 2010 754 759
27. A. Deshpande, C. Pant, M.P. Anderson, C.J. Donskey, and T.J. Sferra Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence Pediatr Infect Dis J 32 2013 1138 1140
28. D.M. McCarthy Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence? J Clin Gastroenterol 46 2012 350 353
29. W. Liu, S.S. Baker, J. Trinidad, A.L. Burlingame, R.D. Baker, and J.G. Forte Inhibition of lysosomal enzyme activities by proton pump inhibitors J Gastroenterol 48 2013 1343 1352
30. X. Huo, X. Zhang, C. Yu, Q. Zhang, E. Cheng, and D.H. Wang In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1 Gut 63 2014 1042 1052
31. J.H. Wandall Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245 Gut 33 1992 617 621
32. K. Zedtwitz-Liebenstein, C. Wenisch, S. Patruta, B. Parschalk, F. Daxbock, and W. Graninger Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity Crit Care Med 30 2002 1118 1122
33. G. Agastya, B.C. West, and J.M. Callahan Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro Immunopharmacol Immunotoxicol 22 2000 357 372
34. A. Inan, M. Sen, O. Surgit, M. Ergin, and M. Bozer Effects of the histamine H2 receptor antagonist famotidine on the healing of colonic anastomosis in rats Clinics (Sao Paulo) 64 2009 567 570
35. Y. Ashida, M. Denda, and T. Hirao Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment J Invest Dermatol 116 2001 261 265
36. A.W. DuPont, and H.L. DuPont The intestinal microbiota and chronic disorders of the gut Nat Rev Gastroenterol Hepatol 8 2011 523 531
37. T. Kanno, T. Matsuki, M. Oka, H. Utsunomiya, K. Inada, and H. Magari Gastric acid reduction leads to an alteration in lower intestinal microflora Biochem Biophys Res Commun 381 2009 666 670
38. S.M. Vindigni, E.K. Broussard, and C.M. Surawicz Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond Expert Rev Gastroenterol Hepatol 7 2013 615 628
39. J. Shaklee, D.M. Zerr, A. Elward, J. Newland, K. Leckerman, and L. Asti Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool Pediatr Infect Dis J 30 2011 e38 e40